Current Cancer Drug Targets
Volume 20, 11 Issues, 2020
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Ranking and Category
-
135th of 229 in
Oncology
Contents
Current Cancer Drug Targets, Volume 20 - Number 2
Biography Open Access
Review Article
Nordihydroguaiaretic Acid in Therapeutics: Beneficial to Toxicity Profiles and the Search for its Analogs
, 20(2): 86 - 103Geraldine Sandana Mala John, Satoru Takeuchi, Ganesh Venkatraman* and Suresh Kumar Rayala*
DOI: 10.2174/1568009619666191022141547
Nordihydroguaiaretic Acid in Therapeutics: Beneficial to Toxicity Profiles and the Search for its Analogs
Review Article
Anti-tumor Activity of Propofol: A Focus on MicroRNAs
, 20(2): 104 - 114Milad Ashrafizadeh, Zahra Ahmadi, Tahereh Farkhondeh and Saeed Samarghandian*
DOI: 10.2174/1568009619666191023100046
Anti-tumor Activity of Propofol: A Focus on MicroRNAs
Review Article
Novel Mechanistic Insights into the Anti-cancer Mode of Arsenic Trioxide
, 20(2): 115 - 129Md Wahiduzzaman, Akinobu Ota* and Yoshitaka Hosokawa
DOI: 10.2174/1568009619666191021122006
Novel Mechanistic Insights into the Anti-cancer Mode of Arsenic Trioxide
Review Article
Resveratrol as an Adjuvant for Normal Tissues Protection and Tumor Sensitization
, 20(2): 130 - 145Keywan Mortezaee, Masoud Najafi*, Bagher Farhood*, Amirhossein Ahmadi*, Dheyauldeen Shabeeb and Ahmed E. Musa
DOI: 10.2174/1568009619666191019143539
Resveratrol as an Adjuvant for Normal Tissues Protection and Tumor Sensitization
Research Article
Uptake of [¹⁸F]tetrafluoroborate in MCF-7 Breast Cancer Cells is Induced after Stimulation of the Sodium Iodide Symporter
, 20(2): 146 - 155Marc Lehmacher*, Antje Stolzenburg and Samuel Samnick
DOI: 10.2174/1568009619666191016145602
Uptake of [¹⁸F]tetrafluoroborate in MCF-7 Breast Cancer Cells is Induced after Stimulation of the Sodium Iodide Symporter
Research Article
CDK12 Promotes Breast Cancer Progression and Maintains Stemness by Activating c-myc/β -catenin Signaling
, 20(2): 156 - 165Fang Peng, Chuansheng Yang, Yanan Kong, Xiaojia Huang, Yanyu Chen, Yangfan Zhou, Xinhua Xie* and Peng Liu*
DOI: 10.2174/1568009619666191118113220
CDK12 Promotes Breast Cancer Progression and Maintains Stemness by Activating c-myc/β -catenin Signaling
  |
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net